News | Transesophageal Echo (TEE) | June 13, 2024

Visura Technologies to Feature TEECAD mini for Use with Smaller Transesophageal Echocardiography (TEE) Probes During ASE 2024

Visura Technologies, Inc., a privately-owned medical device company, has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. The company, led by President & CEO Christine Horton, will be participating in the American Society of Echocardiography Scientific Sessions (ASE 2024) to be held June 14-16 in Portland, OR.

Medical device company Visura Technologies, Inc. has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. The company, led by President & CEO Christine Horton, will be participating in the American Society of Echocardiography Scientific Sessions (ASE 2024) to be held June 14-16 in Portland, OR.

Medical device company Visura Technologies, Inc. has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. The company, led by President & CEO Christine Horton, will be participating in the American Society of Echocardiography Scientific Sessions (ASE 2024) to be held June 14-16 in Portland, OR. Image courtesy: Visura Technologies, Inc.


June 13, 2024 — Visura Technologies, Inc., a privately owned medical device company, has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. The company will be participating in the American Society of Echocardiography Scientific Sessions (ASE 2024) to be held June 14-16 in Portland, OR, allowing the opportunity for cardiology clinicians to see Visura’s TEECAD System at its Innovation Station, a demonstration center for physicians to experience the benefits of real-time visualization.

Visura’s TEECAD System is the world’s first, FDA-cleared disposable camera that seamlessly connects to TEE probes to provide real-time visualization during esophageal intubation for more efficient and effective probe placement. There are an estimated 1.7M TEE procedures performed annually in the U.S. with TEE procedures growing at an annual rate of 10%, according to the company.

A written statement about the TEECAD mini reported that, in 2023, it commercialized the first and only digital camera that allows for real-time visualization for use with adult TEE probes. The company will now focus on expanding the proprietary and patent-protected camera system for use with smaller probes for procedures in adult patients with anatomical requirements not currently served by standard TEE probe sizes.

The TEECAD mini program builds on several recent milestones for the company. In addition to expanding its clinical and commercialization teams, the company increased evaluations and traction at key medical centers over the last quarter by 85%. The company counts some of the largest and most prestigious hospital systems in the country as customers and evaluators.

“Since the development of TEE probes in the 1970s, there have been few significant updates,” said David Marmor, M.D., Visura’s founder and chief medical officer. Marmor added, “The introduction of TEECAD was a critical step in TEE procedural evolution. Now probe manufacturers are committed to producing smaller sizes, further validating the need for a camera to allow real-time visualization during the probe placement.”

“We see the potential of a smaller size TEECAD as being an important part of our patent-protected product portfolio,” said Christine Horton, president and chief executive officer of Visura Technologies.

Clinical data also supports the use of TEECAD, according to the company. Last year at the annual American Society of Echocardiology (ASE) meeting, Sunil Mankad, M.D., Director of Transesophageal Echocardiography, Division of Cardiovascular Ultrasound, Mayo Clinic, shared for the first time data on the use of the technology. The experience in all cases was that TEECAD was safe and effective in imaging the esophagus and surrounding anatomical structures. It reduced the time needed for accurate probe placement and promoted first-pass intubation success with no adverse events. It may also help reduce the cost-of-care for TEE, as additional staff do not need to be called in to support intubations. TEECAD shows promise as a new but essential device for cardiology TEE intubation.1,2

Visura is a Bloomington, MN-based privately held medical device company dedicated to delivering state-of-art visualization solutions to improve the safety and success of TEE probe intubation. Visura developed the TEECAD System, the world's first and only, FDA-cleared, disposable camera that seamlessly connects to a TEE probe, providing physicians real-time visualization for more efficient and effective probe placement to support safer intubation. For more information, please visit

More information: www.visuratechnologies.com

References:

1 Early Results of the TEECAD System in 15 TEE Patients at the Mayo Clinic Rochester. White Paper. Sunil V. Mankad. David Marmor. May 2023.

2 2023 ASE Poster presentation. New Commercially Available Digital Camera System Provides Real-Time Visualization During Transesophageal Echocardiography (TEE) Probe Placement. Sunil Mankad.

For additional ASE2024 news, follow DAIC ASE Scientific Sessions coverage here.


Related Content

News | Transesophageal Echo (TEE)

May 29, 2024 — Congenital heart disease (CHD) is one of the most common congenital anomalies worldwide, which brings a ...

Home May 29, 2024
Home
News | Transesophageal Echo (TEE)

January 31, 2024 — Royal Philips, a global leader in health technology, announced that its latest TEE transducer ...

Home January 31, 2024
Home
News | Transesophageal Echo (TEE)

June 30, 2022 — Clarius Mobile Health, a leading provider of high-definition wireless ultrasound systems, and ImaCor Inc ...

Home June 30, 2022
Home
News | Transesophageal Echo (TEE)

June 7, 2022 — Visura Technologies, Inc., a privately-held medical device company dedicated to delivering state-of-the ...

Home June 07, 2022
Home
News | Transesophageal Echo (TEE)

February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensive ...

Home February 05, 2019
Home
Sponsored Content | Case Study | Transesophageal Echo (TEE) | Cyril Danielkutty B.E., Dillon Weiss, B.S., Chad A Kliger, M.D., M.S.

Transcatheter interventions have become a mainstay in cardiac care as treatments for structural and congenital heart ...

Home September 05, 2018
Home
Technology | Transesophageal Echo (TEE)

July 10, 2018 — Evanston, Ill.-based startup Visura Technologies has received 510(k) clearance from the U.S. Food and ...

Home July 10, 2018
Home
Technology | Transesophageal Echo (TEE)

June 20, 2017 — Dutch medical device company Stroke2prevent BV recently announced it has received U.S. Food and Drug ...

Home June 20, 2017
Home
News | Transesophageal Echo (TEE)

April 21, 2016 — CS Medical announced the release of their newest product designed to aid in the circle of care for ...

Home April 21, 2016
Home
Subscribe Now